Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-015048
Filing Date
2025-10-17
Accepted
2025-10-17 14:01:41
Documents
1
Period of Report
2025-10-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-71051.html 4  
1 PRIMARY DOCUMENT marketforms-71051.xml 4 8284
  Complete submission text file 0001214659-25-015048.txt   9806
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Jung Cassie (Reporting) CIK: 0001960154 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 251400050